CPC A61K 38/12 (2013.01) [A23L 33/00 (2016.08); A23L 33/18 (2016.08); A61K 38/05 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C07K 5/12 (2013.01); A23V 2002/00 (2013.01); A23V 2200/308 (2013.01); A23V 2250/55 (2013.01); A61P 1/16 (2018.01)] | 14 Claims |
1. A method of treating a subject suffering from a kidney disease or kidney damage,
said method comprising administering an effective amount of a composition to the subject,
wherein the composition comprises cyclo-histidine-proline (CHP) or a pharmaceutically acceptable salt thereof, as an active ingredient, and
wherein the kidney disease or kidney damage excludes acute renal failure.
|